These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. The inhibitory effect of Isoflavones isolated from Caesalpinia pulcherrima on aldose reductase in STZ induced diabetic rats. Kumar MP, Sankeshi V, Naik RR, Thirupathi P, Das B, Raju TN. Chem Biol Interact; 2015 Jul 25; 237():18-24. PubMed ID: 25986969 [Abstract] [Full Text] [Related]
46. Effects of a novel potent aldose reductase inhibitor, GP-1447, on aldose reductase activity in vitro and on diabetic neuropathy and cataract formation in rats. Ashizawa N, Yoshida M, Sugiyama Y, Akaike N, Ohbayashi S, Aotsuka T, Abe N, Fukushima K, Matsuura A. Jpn J Pharmacol; 1997 Feb 25; 73(2):133-44. PubMed ID: 9074947 [Abstract] [Full Text] [Related]
48. Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs. Engerman RL, Kern TS. Diabetes; 1993 Jun 25; 42(6):820-5. PubMed ID: 8495805 [Abstract] [Full Text] [Related]
49. [Prevention of pericyte ghost formation in retinal capillaries by aldose reductase inhibitor in galactose-fed dogs with diabetic retinopathy]. Akagi Y, Terubayashi H, Ikebe H, Kador PF, Kinoshita JH. Nippon Ganka Gakkai Zasshi; 1988 Sep 25; 92(9):1479-84. PubMed ID: 3145681 [No Abstract] [Full Text] [Related]
50. Effect of aldose reductase inhibitor on experimental diabetic cataract monitored by laser Raman spectroscopy. Mizuno A, Nozawa H, Yaginuma T, Matsuzaki H, Ozaki Y, Iriyama K. Exp Eye Res; 1987 Jul 25; 45(1):185-6. PubMed ID: 3115805 [No Abstract] [Full Text] [Related]
51. Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy. Dagher Z, Park YS, Asnaghi V, Hoehn T, Gerhardinger C, Lorenzi M. Diabetes; 2004 Sep 25; 53(9):2404-11. PubMed ID: 15331552 [Abstract] [Full Text] [Related]
52. Genetic analysis of aldose reductase in diabetic complications. Chung SS, Chung SK. Curr Med Chem; 2003 Aug 25; 10(15):1375-87. PubMed ID: 12871135 [Abstract] [Full Text] [Related]
54. The contributions of Jin H. Kinoshita to aldose reductase research. Kador PF. Exp Eye Res; 1990 Jun 11; 50(6):615-20. PubMed ID: 2115449 [Abstract] [Full Text] [Related]
55. Inhibition of lens aldose reductase by flavonoids--their possible role in the prevention of diabetic cataracts. Varma SD, Kinoshita JH. Biochem Pharmacol; 1976 Nov 15; 25(22):2505-13. PubMed ID: 825129 [No Abstract] [Full Text] [Related]
57. Aldose reductase inhibitors and diabetic complications. Raskin P, Rosenstock J. Am J Med; 1987 Aug 15; 83(2):298-306. PubMed ID: 3113248 [No Abstract] [Full Text] [Related]
58. Early retinal microangiopathy: prevention with aldose reductase inhibitors. Robison WG, Kador PF, Kinoshita JH. Diabet Med; 1985 May 15; 2(3):196-9. PubMed ID: 2952420 [No Abstract] [Full Text] [Related]
59. Recent studies of aldose reductase enzyme inhibition for diabetic complications. Suzen S, Buyukbingol E. Curr Med Chem; 2003 Aug 15; 10(15):1329-52. PubMed ID: 12871133 [Abstract] [Full Text] [Related]
60. [The role of lens epithelium in cataract formation in diabetic rats]. Fan W, Yan M, Hu Y, Li G. Hua Xi Yi Ke Da Xue Xue Bao; 1998 Jun 15; 29(2):185-8. PubMed ID: 10684012 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]